Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | 479,989 | reported | 22 May 2026 | tx 161+2,810,090−978,345 |
| PENWEST PHARMACEUTICALS CO | 19,500 | reported | 11 Jun 2008 | tx 8+342,500 |
| GENE LOGIC INC | 6,250 | reported | 18 Jan 2010 | tx 3+246,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23,250 | — | |
| 22 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 10,926 | 26.78 USD | |
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23,250 | 0.00 USD | deriv |
| 17 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | — | |
| 18 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,129 | 26.76 USD | |
| 17 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | 0.00 USD | deriv |
| 11 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7,120 | — | |
| 12 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 3,322 | 26.71 USD | |
| 11 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7,120 | 0.00 USD | deriv |
| 17 Apr 2026 | SALE | KalVista Pharmaceuticals, Inc. | 9,550 | 20.22 USD | |
| 16 Apr 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20,312 | — | |
| 16 Apr 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 20,312 | 0.00 USD | deriv |
| 06 Mar 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 15,625 | — | |
| 09 Mar 2026 | SALE | KalVista Pharmaceuticals, Inc. | 6,693 | 16.08 USD | |
| 06 Mar 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 15,625 | 0.00 USD | deriv |
| 23 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 10,034 | 15.57 USD | |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23,250 | — | |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 23,250 | 0.00 USD | deriv |
| 18 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,038 | 15.00 USD | |
| 17 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | — | |
| 17 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | 0.00 USD | deriv |
| 12 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 3,354 | 15.70 USD | |
| 11 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7,120 | — | |
| 11 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 7,120 | 0.00 USD | deriv |
| 16 Jan 2026 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 325,000 | 0.00 USD | deriv |